Login / Signup

IL-1β + TGF-β2 dual-licensed mesenchymal stem cells have reduced major histocompatibility class I expression and positively modulate tenocyte migration, metabolism, and gene expression.

Drew W KochAnna FronebergerAlix BerglundShannon ConnardAlexis SoutherLauren V Schnabel
Published in: Journal of the American Veterinary Medical Association (2024)
Our data indicate that conditioned media containing paracrine factors secreted from dual-licensed MSCs significantly modulates in vitro tenocyte function, which may confer benefits in vivo to healing tendons following injury. Additionally, due to reduced MHC class I expression in dual-licensed MSCs, this technique may also provide an avenue to provide an effective "off-the-shelf" allogenic source of MSCs.
Keyphrases
  • mesenchymal stem cells
  • umbilical cord
  • gene expression
  • poor prognosis
  • bone marrow
  • dna methylation
  • cell therapy
  • stem cells
  • long non coding rna
  • signaling pathway
  • machine learning
  • artificial intelligence